(Available Commercially with reasonable lead time)
| S.No. | Product Name | CAS No | Therepitic Catogery |
|---|---|---|---|
| 1 | (±)-4-Fluoro-a-(2-methyl-1-oxopropyl)-g-oxo-N, b-diphenyl benzene butanamide+B1:F4 | 125971-96-2 | Atorvastatin |
| 2 | 2, 3, 4, 6-Tetrakis-O-trimethylsilyl-D-glucono-1,5-lactone | 32384-65-9 | Canagliflozin, Dapagliflozin, Empagliflozin, Ipragliflozin |
| 3 | 4,6-Dichloro-2-methyl pyrimidine | 1780-26-3 | Dasatinib |
| 4 | 2-(4-ethoxybenzyl)-4-iodo-1-chloro benzene | 1103738-29-9 | Dapagliflozin |
| 5 | 2-(4-ethoxybenzyl)-4-bromo-1-chloro benzene | 461432-23-5 | Dapagliflozin |
| 6 | (S)-3-(4-(5-bromo-2-chlorobenzyl)phenoxy)tetrahydrofuran | 915095-89-5 | Empagliflozin |
| 7 | (4-(5-bromo-2-chlorobenzyl)phenoxy)(tert-butyl)dimethysilane | 864070-19-9 | Empagliflozin |
| 8 | (S)+tetrahydrofuran-3-ol | 86087-23-2 | Empagliflozin |
| 9 | tert-butyl(4-(2-chloro-5-iodobenzyl)phenoxy)dimethylsilane | 1800112-28-0 | Empagliflozin |
| 10 | 4-(5-Bromo-2-chlorobenzyl)phenol | 864070-18-8 | Empagliflozin |
| 11 | 6-Chloro-2-Oxindol | 56341-37-8 | Ziprasidone |
| 12 | 5-Chloroethyl-6-Cloro-2-oxindole | 118289-55-7 | Ziprasidone |
| 13 | N-BOC -L-pyroglutamic acid methyl ester | 108963-96-8 | Raxatrigine |
| 14 | Benzyloxy-4-bromo benzene | 6793-92-6 | Raxatrigine |
| 15 | 2-(N-Triphenyl methyl tetrazyl)-4’-bromo methyl biphenyl(TTBB) | 133051-88-4 | Losartan, Irbesartan, Valsartan, Candesartan, Olmesartan |
| 16 | Losartan Base | 114798-26-4 | Losartan Potassium |
| 17 | 6-Bromo-3-hydroxypyrazine-2-carboxamide | 259793-88-9 | Favipiravir |
| 18 | 4,6-dichloro-2-propylthio-pyrimidine-5-amin | 145783-15-9 | Ticagrelor |
| 19 | Vanillylamine Hydrochloride | 7149-10-2 | |
| 20 | (4-Cyano phenyl) amino acetic acid | 42288-26-6 | Dabigatran |
| 21 | Ethyl-3{[3-amino-4-methylamino)benzoyl] (pyridine-2-yl) amino) propanoate | 212322-56-0 | Dabigatran |
| 22 | N-[[2-[[[4-(AMINOIMINOMETHYL) PHENYL]AMINO]METHYL]-1-METHYL-1H-BENZIMIDAZOL-5-YL] CARBONYL]-N-(2-PYRIDINYL)-BETA-ALANINE ETHYL ESTER HYDROCHLORIDE | 211914-50-0 | Dabigatran |
| 23 | (N-[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-alanine Ethyl Ester | 211915-84-3 | Dabigatran |
| 24 | Meldrum's acid | 2033-24-1 | Heterocyclic compounds |
| 25 | p-toluenesulfonylmethyl Isocyanide (TosMic) | 36635-61-7 | Bempedoic acid |
Disclaimer:
Product under patent will not be sold until patent expiration in buyers country purchase of any patented product will be sole responsibility of the buyer